Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The history now shows a new revision entry v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's history rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-29T18:53:14.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    No additions or deletions are listed for this study history. As a result, there are no textual changes to interpret.
    Difference
    0.1%
    Check dated 2026-08-15T23:12:13.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.5) was added on 2026-08-06 with a 'Study Status' note, while the prior revision (v3.6.4) was removed on 2026-05-12.
    Difference
    0.3%
    Check dated 2026-08-08T18:02:15.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added to the history, replacing the previous v3.6.3. This reflects a platform/UI update to the record history page rather than any substantive change to the trial data.
    Difference
    0.1%
    Check dated 2026-07-25T08:24:45.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The footer now shows revision v3.6.3, replacing v3.6.2. This reflects a minor update to the record history page interface.
    Difference
    0.1%
    Check dated 2026-07-03T22:08:50.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page’s revision notice updated from v3.6.0 to v3.6.2. This reflects a newer version of the site's interface/backend for the Record History view.
    Difference
    0.1%
    Check dated 2026-06-26T23:44:23.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.